Granules India

Last updated

Granules India Ltd.
Type Public
BSE:  532482
NSE:  GRANULES
Industry Pharmaceuticals
Founded1984
FounderMr. Krishna Prasad Chigurupati
Headquarters Hyderabad, India
Area served
Worldwide
Key people
Krishna Prasad Chigurupati (CMD)
Harsha Chigurupati (ED)
Sandeep Neogi (CFO)
GSR Prasad(COO)
Priyanka Chigurupati (ED)
Products Paracetamol, Ibuprofen, Methocarbamol, Metformin, Guaifenesin, etc.
RevenueFY 2018–19
INR 2,279 Crore
FY 2018–19
INR 236 Crore
Number of employees
2789
Website www.granulesindia.com

Granules India Limited is an Indian pharmaceutical manufacturing company based in Hyderabad, India. Granules manufactures several off-patent drugs, including Paracetamol, Ibuprofen, Metformin and Guaifenesin, on a large scale for customers in the regulated and rest of the world markets. Granules India Limited entered CRAMS segment, which focuses on contract research and manufacturing. [1] [2]

Contents

History

Granules India was formed in 1984 as Triton Laboratories. Triton produced Paracetamol API at its Bonthapally factory on the outskirts of Hyderabad. [3] Triton scientists found a more efficient way to produce the Paracetamol API, which led to lower capital and raw material requirements.[ citation needed ] In 1987, Triton became the only Indian company aside from Dr. Reddy's Laboratories to export pharmaceutical products to the U.S.[ citation needed ]

Though Triton was growing as an API manufacturer, management decided it could create a value added version of its product.[ citation needed ] In order to distinguish itself from competitors, Triton management pioneered the concept of manufacturing and selling in bulk granulated Paracetamol, also known as direct compressible grade material (DC), or "PFI".[ citation needed ] In 1990, it opened its second manufacturing facility at Jeedimetla to produce multiple APIs.

In 1991, [4] management set up a new entity, which was incorporated as Granules India Limited. Soon after Granules applied the PFI concept to other APIs, set up a PFI facility at Jeedimetla and began exporting the material to various markets including the U.S., Germany and Australia. [5]

In 1995, [4] Granules became a public company, after having initial public offerings on the Bombay and Hyderabad Stock Exchanges. [6]

In 2013, Granules India acquires Auctus Pharma for Rs 120 crore. [7]

In 2016, Granules India commissioned a new state of the art manufacturing unit that hosts facilities for Oncology and High Potent APIs. This new plant is located in Visakhapatnam.

In order to secure API for its Ibuprofen PFI, Granules formed a joint-venture with Hubei Biocause Heilen Pharmaceutical to create Granules Biocause in Wuhan, China. Granules India Limited on announced its intention to divest its entire equity shareholding in Granules Biocause Pharmaceuticals Co. Ltd. by selling its stake to joint venture partner. [8]

Infrastructure

Granules has seven manufacturing facilities; six are in India while the seventh is through a joint-venture with Hubei Biocase in Wuhan, China. The company also has two research centres, at Hyderabad and Pune.

Gagillapur Plant Granules GGP plant1.jpg
Gagillapur Plant

The Gagillapur facility is located near Hyderabad and has a Finished Dosage block, a PFI block and a research & development facility.[ citation needed ]

Granules commissioned the world's single largest PFI plant in Gagillapur in August 2003 with a batch size of 6 MT and an annual capacity of 7,200 MT per annum. The plant received its US FDA approval within six months of commissioning.[ citation needed ]

See also

Related Research Articles

Ranbaxy Laboratories Limited was an Indian multinational pharmaceutical company that was incorporated in India in 1961 and remained an entity until 2014. The company went public in 1973. Ownership of Ranbaxy changed twice over the course of its history.

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.

<span class="mw-page-title-main">Biocon</span> Indian multinational biopharmaceutical company

Biocon Limited is an Indian biopharmaceutical company based in Bangalore. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.

The pharmaceutical industry is one of the leading industries in the People's Republic of China, covering synthetic chemicals and drugs, prepared Chinese medicines, medical devices, apparatus and instruments, hygiene materials, packing materials, and pharmaceutical machinery. China has the second-largest pharmaceutical market in the world as of 2017 which is worth US$110 billion. China accounts for 20% of the world's population but only a small fraction of the global drug market. China's changing health-care environment is designed to extend basic health insurance to a larger portion of the population and give individuals greater access to products and services. Following the period of change, the pharmaceutical industry is expected to continue its expansion.

The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 50% of all vaccines manufactured in the world. With industry standards compliant mega production capabilities and large number of skilled domestic workforce, Indian exports meet the standards and requirements of highly regulated markets of USA, UK, European Union and Canada. According to the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, domestic pharmaceutical market turnover reached Rs 129,015 crore in 2018, growing 9.4 per cent year-on-year and exports revenue was US$17.28 billion in FY18 and US$19.14 billion in FY19.

<span class="mw-page-title-main">Genome Valley</span> Science Parks

Genome Valley is an Indian high-technology business district spread across 2,000-acre (8.1 km2)/(3.1 sq mi) in Hyderabad, India. It is located across the suburbs, Turakapally, Shamirpet, Medchal, Uppal, Patancheru, Jeedimetla, Gachibowli and Keesara. The Genome Valley has developed as a cluster for Biomedical research, training and manufacturing. Genome Valley is now into its Phase III, which is about 11 kms from the Phase I and II with the total area approximately 2,000-acre (8.1 km2).

<span class="mw-page-title-main">Kalyani Group</span> Indian industrial conglomerate

The Kalyani Group is an Indian multinational conglomerate focused in four primary sectors, viz. Engineering Steel, Automotive & Non-Automotive Components, Renewable Energy & Infrastructure and Specialty Chemicals. It has also made strides into defence manufacturing, which has been showcased in DefExpo 2020.

<span class="mw-page-title-main">HLL Lifecare</span>

HLL Lifecare Limited (HLL) is an Indian healthcare product manufacturing company based in Thiruvananthapuram, Kerala, India. A Government of India-owned corporation.

Bharat Forge Limited is an Indian multinational company involved in forging, automotives, energy, construction and mining, railways, marine, aerospace and defence industries. The company was founded by Nilkanthrao A. Kalyani on 19 June 1961. Headquartered in Pune, Maharashtra, it is the flagship company of the Kalyani Group. Bharat Forge's Special Economic Zone (SEZ) named Khed City is spread over an area of 1,000 hectares in Khed taluka, and is the largest SEZ in Pune district.

Australian Pharmaceutical Industries Limited (API) is a health and beauty company in Australia that is involved in pharmaceutical distribution, retailing and manufacturing. API is Australia's largest wholesale distributor of pharmaceutical and allied products. The company is involved in retailing through company-owned stores and franchise operations. API operates in the retail health and beauty industry under the following brands: Priceline, Priceline Pharmacy, Soul Pattinson and Pharmacist Advice. API was acquired by Wesfarmers for A$774 million in March 2022.

<span class="mw-page-title-main">Sun Pharma</span> Indian multinational pharmaceutical company

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin.

WuXi AppTec is a global pharmaceutical, biopharmaceutical, and medical device company.

<span class="mw-page-title-main">Jeedimetla</span> Suburb in Medchal, Telangana, India

Jeedimetla is a suburb of Hyderabad in the Indian state of Telangana.

<span class="mw-page-title-main">Vivimed Labs</span>

Vivimed Labs Limited is an India-based global supplier of specialty chemicals and pharmaceuticals. Headquartered in Hyderabad, India. Vivimed is a manufacturer of active pharmaceutical ingredients, active ingredients for home and personal care, hair dyes, imaging chemicals and photochromics.

<span class="mw-page-title-main">Lupin Limited</span> Indian multinational pharmaceutical company

Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.

Unichem Laboratories was founded in 1944 by Padmabhushan Late Mr. Amrut V Mody, a pioneer in the Indian pharmaceuticals business.

<span class="mw-page-title-main">Hydrocodone/ibuprofen</span> Combination drug

Hydrocodone/ibuprofen (INNs), sold under the brand name Vicoprofen, is a fixed-dose combination analgesic medication used in short-term therapy to relieve severe pain. Vicoprofen combines the analgesic and antitussive properties of hydrocodone with the analgesic, anti-inflammatory, and antipyretic properties of ibuprofen. In contrast to hydrocodone/acetaminophen combination analgesics such as Vicodin, this hydrocodone/ibuprofen avoids some of the liver toxicity which may occur from acetaminophen, but still presents significant dangers in hydrocodone overdose, namely respiratory depression. Vicoprofen is supplied in a fixed dose combination tablet which contains hydrocodone bitartrate, USP 7.5 mg with ibuprofen, USP 200 mg. Additional strengths of generic Vicoprofen are now available, in combinations of 5 mg/200 mg and 10 mg/200 mg respectively.

<span class="mw-page-title-main">Piramal Group</span> Indian conglomerate

The Piramal Group is an Indian multinational conglomerate that has presence across various sectors such as healthcare, life sciences, drug discovery, financial services, alternative investment and real estate.

<span class="mw-page-title-main">Laurus Labs</span> Indian pharmaceutical company

Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients (APIs), generic formulations, custom synthesis and biotechnology. The company was founded in 2005 by Satyanarayana Chava.

<span class="mw-page-title-main">Divi's Laboratories</span> Indian pharmaceutical company

Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's second most valuable pharmaceutical company by market capitalization.

References

  1. "Granules India signs deal with Matchland Pty Ltd".
  2. "Granules India". Moneycontrol.com. 10 May 2007. Retrieved 10 December 2009.
  3. "Triton Laboratories Ltd Company info".
  4. 1 2 "Granules India Limited – About Us – Milestones". Granulesindia.com. Archived from the original on 17 July 2010. Retrieved 30 September 2010.
  5. "Granules ties up with GSK Healthcare R&D".
  6. "Granules, Amneal Pharma get FDA nod". Business Standard. 2 August 2006. Retrieved 10 December 2009.
  7. "Granules India acquires Auctus Pharma for Rs 120 crore". www.businesstoday.in. Retrieved 10 February 2020.
  8. "Granules India takes stake in Chinese firm". In-pharmatechnologist.com. Retrieved 30 September 2010.

8. https://health.economictimes.indiatimes.com/news/pharma/granules-india-to-divest-its-stake-in-its-joint-venture-located-in-china/71596498